Centinel Spine's Prodisc C SK was used in its first commercial case, the devicemaker said Nov. 10.
Spinal Tech
NuVasive saw key milestones for its spine technologies in the third quarter, according to a Nov. 9 earnings call.
Surgalign's board of directors on Nov. 8 approved a corporate restructuring program that's expected to save the company $30 million to $35 million in 2023.
NuVasive on Nov. 9 posted third quarter net sales of $295.3 million.
Zimmer Biomet on Nov. 9 posted third-quarter revenue of $213.3 million.
Advertisement
Here are four updates in total hip and knee replacement technology since Oct. 9:
Eminent Spine's standalone anterior lumbar interbody fusion system earned FDA 510(k) approval, the devicemaker said Nov. 8.
Updates on Surgalign's Holo Portal, and five more key developments from spine and orthopedic devicemakers since Nov. 2:
As Globus Medical's robotic footprint grows, the medtech company has its eyes on augmented reality in spine surgery, executive vice president and CEO Dan Scavilla said in a Nov. 8 earnings call.
NuVasive launched the NuVasive Tube System and Excavation Micro for minimally invasive transforaminal lumbar interbody fusions and decompressions, the devicemaker said Nov. 7.